Vivos Therapeutics Announces Material Debt Reduction
Stocks in this Quantisnow insightHealth Care
Historical context for VVOS
Across the 25 sessions after earlier VVOS headlines, the stock closed higher 7 times and lower 16 times, with a median move of 5.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | VVOS | SPY |
|---|---|---|---|
| Aug 28, 2026 | Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center | -13.0% | -0.2% |
| Aug 25, 2026 | Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers | -4.2% | +0.3% |
| Aug 20, 2026 | Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment | +1.2% | -0.8% |
| Aug 17, 2026 | Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update | -12.3% | -0.5% |
| Aug 14, 2026 | Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call | +12.4% | -0.2% |
| Aug 11, 2026 | Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations | -0.9% | -0.3% |
Quantisnow market dataNASDAQ
VVOS
Vivos Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2020
Get push alerts for VVOS
Full VVOS profile on Quantisnow Follow VVOS and get a push notification the moment its next story breaks.